Annual Midwest Regional ASCO Review 2021
2021 ASCO Review on EGFR Resistance Strategies in NSCLC: Amivantamab & Lazertinib Data
By
Annual Midwest Regional ASCO Review 2021
FEATURING
Patrick Forde
By
Annual Midwest Regional ASCO Review 2021
FEATURING
Patrick Forde
Login to view comments.
Click here to Login
Videos